Since the onset of the COVID-19 pandemic, multiple vaccines and treatments have been proposed to combat the disease. However, one limitation of these vaccines and treatments is that they are often developed for a specific form of a virus–meaning they maybe less effective against new variants of the disease.
Professor Thomas Webster thinks that this could be achieved by using nanomaterials, specifically those that bind to proteins on the surface of SARS-CoV-2, the virus responsible for COVID-19, and inhibit its ability to infect human cells.
Read the original article: https://doi.org/10.1016/j.onano.2022.100054
Read more about his work in Research Outreach